| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $358.4M | — | +30.2% |
| Cost of Revenue | $272.2M | — | +30.1% |
| Gross Profit | $86.2M | — | +30.6% |
| R&D Expense | $16.3M | — | +8.2% |
| SG&A Expense | $13.1M | — | +43.1% |
| Operating Income | $26.6M | — | +69.2% |
| Pre-tax Income | $29.1M | — | +63.4% |
| Income Tax | $8.2M | — | +105.9% |
| Net Income | $20.9M | — | +51.2% |
| EPS (Basic) | $0.17 | — | +54.5% |
| EPS (Diluted) | $0.16 | — | +45.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $338.8M | +5.6% | +37.8% |
| Accounts Receivable | $117.2M | +14.5% | +17.2% |
| Current Assets | $472.5M | +7.1% | +30.7% |
| Total Assets | $698.6M | +4.6% | +18.2% |
| Current Liabilities | $107.1M | +8.3% | +32.2% |
| Total Liabilities | $115.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $30.5M | — | -39.6% |
| Capital Expenditures | $80K | — | +33.3% |
| Investing Cash Flow | -$9.4M | — | -13.9% |
| Financing Cash Flow | -$3.3M | — | -73.5% |
| Free Cash Flow | $30.4M | — | -39.7% |
| +27.2% |
| Stockholders' Equity | $583.5M | +4.1% | +16.6% |